AHR and cancer: Immunostaining revealed a significant reduction in the level of AFB1 adducts in AHR KD cells as opposed to the WT PLC/PRF/5 cells (Fig. 2f), suggesting a functional link between AHR and the metabolism of AFB1 in hepatocyte-derived cancer cells.